These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 26281199

  • 21. FGF23 Level and Intima-Media Thickness Are Elevated From Early Stages of Chronic Kidney Disease.
    Figurek A, Spasovski G, Popovic-Pejicic S.
    Ther Apher Dial; 2018 Feb; 22(1):40-48. PubMed ID: 28971600
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease.
    Negri AL.
    Int Urol Nephrol; 2014 Jan; 46(1):9-17. PubMed ID: 23296792
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fibroblast growth factor-23 levels are associated with uric acid but not carotid intima media thickness in renal transplant recipients.
    Asicioglu E, Kahveci A, Arikan H, Koc M, Tuglular S, Ozener C.
    Transplant Proc; 2014 Jan; 46(1):180-3. PubMed ID: 24507048
    [Abstract] [Full Text] [Related]

  • 29. Fibroblast growth factor 23 (FGF 23) and phosphocalcic metabolism in chronic kidney disease.
    Torguet-Escuder P, Guasch-Aragay B, Calabia-Martínez J, Martín-Alemany N, García-Méndez I, Maté-Benito G, Clapés-Sánchez E, Sabater-Masdeu M, Fernández-Real JM, Vallès-Prats M.
    Nefrologia; 2012 Jan; 32(5):647-54. PubMed ID: 23013951
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease.
    Nascimento MM, Hayashi SY, Riella MC, Lindholm B.
    Braz J Med Biol Res; 2014 Nov; 47(11):995-1002. PubMed ID: 25296363
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume.
    Kadappu KK, Abhayaratna K, Boyd A, French JK, Xuan W, Abhayaratna W, Thomas L.
    J Am Soc Echocardiogr; 2016 Apr; 29(4):359-67. PubMed ID: 26743735
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The relationships between serum sTWEAK, FGF-23 levels, and carotid atherosclerosis in renal transplant patients.
    Gungor O, Kismali E, Sisman AR, Kircelli F, Carrero JJ, Tatar E, Asci G, Toz H.
    Ren Fail; 2013 Apr; 35(1):77-81. PubMed ID: 23101788
    [Abstract] [Full Text] [Related]

  • 40. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients.
    Balci M, Kirkpantur A, Gulbay M, Gurbuz OA.
    Hemodial Int; 2010 Oct; 14(4):425-32. PubMed ID: 20955275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.